Search Results - "Steiner, Calen A"

Refine Results
  1. 1

    Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis by Xu, Dabo, Chen, Vincent L, Steiner, Calen A, Berinstein, Jeffrey A, Eswaran, Shanti, Waljee, Akbar K, Higgins, Peter D R, Owyang, Chung

    Published in The American journal of gastroenterology (01-07-2019)
    “…Irritable bowel syndrome (IBS) is a common gastrointestinal condition with a heterogeneous pathophysiology. An altered gut microbiome has been identified in…”
    Get full text
    Journal Article
  2. 2

    Aneurysm growth and de novo aneurysms during aneurysm surveillance by Serrone, Joseph C, Tackla, Ryan D, Gozal, Yair M, Hanseman, Dennis J, Gogela, Steven L, Vuong, Shawn M, Kosty, Jennifer A, Steiner, Calen A, Krueger, Bryan M, Grossman, Aaron W, Ringer, Andrew J

    Published in Journal of neurosurgery (01-12-2016)
    “…OBJECTIVE Many low-risk unruptured intracranial aneurysms (UIAs) are followed for growth with surveillance imaging. Growth of UIAs likely increases the risk of…”
    Get full text
    Journal Article
  3. 3

    Structural correlates of apathy in Alzheimer's disease by Apostolova, Liana G, Akopyan, Gohar G, Partiali, Negar, Steiner, Calen A, Dutton, Rebecca A, Hayashi, Kiralee M, Dinov, Ivo D, Toga, Arthur W, Cummings, Jeffrey L, Thompson, Paul M

    Published in Dementia and geriatric cognitive disorders (01-01-2007)
    “…Apathy is the most common noncognitive symptom in Alzheimer's disease (AD). The structural correlates of apathy in AD have not yet been described. We analyzed…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis by Steiner, Calen A, Cartwright, Ian M, Taylor, Cormac T, Colgan, Sean P

    “…The healthy mammalian intestine is lined by a single layer of epithelial cells. These cells provide a selectively permeable barrier to luminal contents and…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis by Berinstein, Jeffrey A., Steiner, Calen A., Regal, Randolph E., Allen, John I., Kinnucan, Jami A.R., Stidham, Ryan W., Waljee, Akbar K., Bishu, Shrinivas, Aldrich, Leslie B., Higgins, Peter D.R.

    Published in Clinical gastroenterology and hepatology (01-04-2019)
    “…As many as 25% of patients diagnosed with ulcerative colitis are hospitalized with an episode of acute severe ulcerative colitis (ASUC).1 The standard of care…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19 by Chen, Vincent L., Hawa, Fadi, Berinstein, Jeffrey A., Reddy, Chanakyaram A., Kassab, Ihab, Platt, Kevin D., Hsu, Chia-Yang, Steiner, Calen A., Louissaint, Jeremy, Gunaratnam, Naresh T., Sharma, Pratima

    Published in Digestive diseases and sciences (01-09-2021)
    “…Background Coronavirus disease-2019 (COVID-19) is a global pandemic. Obesity has been associated with increased disease severity in COVID-19, and obesity is…”
    Get full text
    Journal Article
  11. 11

    Contact‐dependent, polarized acidification response during neutrophil–epithelial interactions by Cartwright, Ian M., Dowdell, Alexander S., Hanson, Camila, Kostelecky, Rachael E., Welch, Nichole, Steiner, Calen A., Colgan, Sean P.

    Published in Journal of leukocyte biology (01-12-2022)
    “…Neutrophil (PMN) infiltration during active inflammation imprints changes in the local tissue environment. Such responses are often accompanied by significant…”
    Get full text
    Journal Article
  12. 12
  13. 13

    AXL Is a Potential Target for the Treatment of Intestinal Fibrosis by Steiner, Calen A, Rodansky, Eva S, Johnson, Laura A, Berinstein, Jeffrey A, Cushing, Kelly C, Huang, Sha, Spence, Jason R, Higgins, Peter D R

    Published in Inflammatory bowel diseases (01-03-2021)
    “…Abstract Background Fibrosis is the final common pathway to intestinal failure in Crohn’s disease, but no medical therapies exist to treat intestinal fibrosis…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    The TNFΔARE Mouse as a Model of Intestinal Fibrosis by Steiner, Calen A., Koch, Samuel D., Evanoff, Tamara, Welch, Nichole, Kostelecky, Rachael, Callahan, Rosemary, Murphy, Emily M., Nguyen, Tom T., Hall, Caroline H.T., Lu, Sizhao, de Zoeten, Edwin F., Weiser-Evans, Mary C.M., Cartwright, Ian M., Colgan, Sean P.

    Published in The American journal of pathology (01-08-2023)
    “…Crohn disease (CD) is a highly morbid chronic inflammatory disease. Although many patients with CD also develop fibrostenosing complications, there are no…”
    Get full text
    Journal Article
  18. 18

    Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model by Johnson, Laura A, Rodansky, Eva S, Tran, Anhdao, Collins, Stephen G, Eaton, Kathryn A, Malamet, Benjamin, Steiner, Calen A, Huang, Sha, Spence, Jason R, Higgins, Peter D R

    Published in Inflammatory bowel diseases (01-02-2022)
    “…Abstract Background Intestinal fibrosis and subsequent intestinal obstruction are common complications of Crohn’s disease (CD). Current therapeutics combat…”
    Get full text
    Journal Article
  19. 19
  20. 20